• Skip to content
  • Contact Us
  • About Us
    • Management Team
    • News

Main navigation

  • Bioanalytical Services
    • GLP Bioanalysis
    • Analysis of Biomarkers
    • DMPK Services
    • Therapeutic Drug Monitoring
  • Microparticle Size
    • Technology
    • ISADE™
  • Cell Based Assays

Invitrox

 

Medical Diagnostic Tool – Invitrox Technologies

Invitrox Technologies is a CLIA certified medical-diagnostic-tool Company based upon revolutionary laser light-scattering technology. We are poised to improve healthcare professionals’ ability to diagnose, monitor, and treat a number of medical conditions affecting millions of patients, ranging from various cardiovascular diseases to multiple types of cancer. Our test devices and the related assays will be easier to use, will provide more accurate test results, and will be less expensive than the competition which have competing approaches to microparticle detection, but do not have developed assays to identify specific diseases.

Intact Cell-Based and Cell Fragment Assays

Our technology EQELS and ISADE uses laser light scattering to detect activities at the cellular (i.e., microparticle) level such as cell membrane fragments that report the cells metabolic state can be exploited as a diagnostic for various diseases and conditions. The speed, accuracy, and ease of use of our products, EQELS and ISADE as well as our accompanying assays, will find broad acceptance in hospitals, reference labs, and possibly even in large physicians’ offices in markets valued at hundreds of millions of dollars per year worldwide.

Please email us for more information at info@invitrox.com

Invitrox, Inc
76 TW Alexander Drive
Research Triangle Park
North Carolina, 27709

 

Invitrox Bioanalytical Services

 

• GLP Bioanalysis

 

• Analysis of BioMarkers

 

• DMPK Services

 

• Therapeutic Drug Monitoring 

Cell Based Assays – EQELS

Microparticle Size

 

• Technology

 

• ISADE

About Invitrox

 

Management Team

 

In the News

 

Contact Us

Copyright @ 2018 Invitrox, Inc